BUSINESS● LOW1h ago · Sep 19, 2026, 4:23 PM
Study attempts to find out how India made expensive diabetes medicines affordable
The Hindu · south asia
India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS12m ago‘We’re not spoiled; we’re still proving ourselves to our father’ — Dangote’s daughtersPremium TimesBUSINESS20m agoLawsuit says AI giants made illegal deal on technology's slowdownCBS News